UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 21, 2006
SUNESIS PHARMACEUTICALS, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware | | 000-51531 | | 94-3295878 |
(State or Other Jurisdictionm
of Incorporation) | | (Commission
File Number) | | (IRS Employer
Identification No.) |
| | | | |
341 Oyster Point Boulevard
South San Francisco, California | |
94080
|
(Address of Principal Executive Offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (650) 266-3500
Not Applicable
(Former Name or Former Address, if Changed Since Last Report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.
On June 21, 2006, Russell Hirsch, M.D., Ph.D. tendered his resignation from the Board of Directors of Sunesis Pharmaceuticals, Inc., and all committees thereof, effective immediately.
* * * * * * * * *
2
SIGNATURE(S)
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | SUNESIS PHARMACEUTICALS, INC. |
| | |
| | |
Date: June 22, 2006 | | |
| By: | /s/ DARYL B. WINTER, PH.D. |
| | Daryl B. Winter, Ph.D. |
| | Senior Vice President, General Counsel |
